![【重磅录像】颜宁:“AI在结构生物学中的未达之地”](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
图片来源:国家药监局官网
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
图片来源:www.trc-canada.com
图片来源:clinicaltrials
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![一年两次!阿斯利康「BTK抑制剂」再添新适应症](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
本篇文章来源于微信公众号: 药时代
发布者:haitao.zhao,转载请首先联系contact@drugtimes.cn获得授权
图片来源:国家药监局官网
图片来源:www.trc-canada.com
图片来源:clinicaltrials
本篇文章来源于微信公众号: 药时代
发布者:haitao.zhao,转载请首先联系contact@drugtimes.cn获得授权